Search Results - "Nazco Casariego, Gloria Julia"

Refine Results
  1. 1
  2. 2

    Reducing the degree of colonisation of venous access catheters by continuous passive disinfection by Gutiérrez Nicolás, Fernando, Nazco Casariego, Gloria Julia, Viña Romero, María Micaela, González García, Jonathan, Ramos Diaz, Ruth, Perez Perez, Jose Antonio

    “…IntroductionThe advent of Luer-type needleless venous access catheters has been accompanied by a growing number of catheter-related bloodstream infections. Our…”
    Get full text
    Journal Article
  3. 3

    Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease by Cantarelli, Lorenzo, Carrillo Palau, Marta, Hernandez Guerra, Manuel, Nazco Casariego, Gloria Julia, Gutierrez Nicolás, Fernando

    Published in Medicina clinica (10-02-2023)
    “…Monitoring plasma levels of Infliximab plays an important role in optimising treatment in patients with inflammatory bowel disease (IBD). The aim of the…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Extended Stability of Reconstituted Lyophilized Erwinia L-asparaginase in Vials by VIÑA-ROMERO, MICAELA M., RAMOS-DIAZ, RUTH, MOURANI-PADRON, IVETTE, GONZALEZ-MENDEZ, HECTOR, GONZALEZ-CRUZ, MACARENA, NAZCO-CASARIEGO, GLORIA JULIA, MERINO-ALONSO, JAVIER F., DIAZ-VERA, JESICA, GUTIÉRREZ-NICOLÁS, FERNANDO

    Published in In vivo (Athens) (01-09-2020)
    “…BACKGROUND/AIML-Asparaginase (L-ASNase) is used as a tumor-inhibitory drug on paediatric acute lymphoblastic leukemia (ALL). ERW-ASNase is commercialised as a…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease by Cantarelli, Lorenzo, Carrillo Palau, Marta, Hernandez Guerra, Manuel, Nazco Casariego, Gloria Julia, Gutierrez Nicolás, Fernando

    Published in Medicina clínica (English ed.) (10-02-2023)
    “…Monitoring plasma levels of Infliximab plays an important role in optimising treatment in patients with inflammatory bowel disease (IBD). The aim of the…”
    Get full text
    Journal Article
  14. 14

    Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease by Cantarelli, Lorenzo, Gutiérrez Valencia, Marta, Leache Alegria, Leire, Sainz Fernandez, Luis Carlos, Erviti Lopez, Juan, Gutiérrez Nicolas, Fernando, Nazco Casariego, Gloria Julia

    Published in Medicina clínica (English ed.) (12-07-2024)
    “…Evidence on the long-term use of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD) is limited. The aim was to evaluate the tolvaptan…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine by Cantarelli, L, Gutiérrez Nicolás, F, Nazco Casariego, G J, García Gil, S

    Published in Revista española de quimioterapia (01-02-2022)
    “…To determine the rate of microbiological confirmation in the diagnosis of Pneumocystis jirovecii pneumonia in patients treated with intravenous pentamidine and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20